Health Minister Nadda inaugurates ‘First Policy Makers’ Forum’ in New Delhi
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
The emergence of new infections in India is a growing concern
This strong performance was primarily on account of a one-time gain from the strategic collaboration between Biocon Biologics and Eris Lifesciences.
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
Q1 Consolidated operating profit Up 8.3%; revenue grows 7% to Rs 3,349 crore
Report highlights significant improvements in adolescent well-being in India
Integrated Disease Surveillance Programme (IDSP) strengthened to improve disease surveillance and rapid data reporting
Subscribe To Our Newsletter & Stay Updated